Skip to main content
. 2022 May 6;12(3):467–475. doi: 10.1177/19418744221098384

Table 1.

Demographics.

Passed SLP evaluation (n = 104) Passed RN screen (n = 673) Passed physician screen (n = 12) P-value
Age, median y (IQR) 70 (63-78) 67 (58-76) 63 (55-72) .04
Female, no. (%) 56 (54%) 284 (42%) 5 (42%) .08
mRS prior to admission, median (IQR) 1 (0-2) 0 (0-2) 0 (0-1) .04
Race, no. (%) .49
 Caucasian 60 (58%) 351/672 (52%) 9 (75%)
 Black 30 (29%) 194 (29%) 3 (25%)
 Asian 2 (2%) 12 (2%) 0 (0%)
 Other 12 (12%) 115 (17%) 0 (0%)
Hispanic, no. (%) 10/100 (10%) 90/643 (14%) 0 (0%) .26
Past medical history, no. (%)
 Hypertension 90 (87%) 566/671 (84%) 11 (92%) .68
 Dyslipidemia 59 (57%) 434/672 (65%) 10 (83%) .12
 Diabetes 37 (36%) 273/672 (41%) 6 (50%) .48
 Prior stroke 27 (26%) 187/672 (28%) 1 (8%) .35
 Atrial fibrillation 24 (23%) 116/671 (17%) 1 (8%) .25
 Coronary artery disease 22 (21%) 152/672 (23%) 1 (8%) .61
 Congestive heart failure 19/103 (18%) 98/672 (15%) 2 (17%) .53
Baseline NIHSS, median (IQR) 11 (5-18) 3 (1-6) 3 (2-5) <.01
Baseline NIHSS subscores, no. (%)
 ≥2 points for level of alertness 40 (38%) 83 (12%) 4 (33%) <.01
 ≥2 points for facial weakness 79 (76%) 241 (36%) 6 (5%) <.01
 ≥1 point for dysarthria a 79 (76%) 241 (36%) 6 (5%) <.01
Anterior circulation only infarction, no. (%) 73/102 (72%) 396/630 (63%) 10/11 (90%) .05
 ASPECTS b , median (IQR) 9 (8-10) 9 (9-10) 10 (8-10) .04
Occlusion of ICA, M1, or basilar, no. (%) 30 (29%) 71 (11%) 3 (25%) <.01
Thrombolysis, no. (%) 24 (23%) 53 (8%) 2 (17%) <.01
Administration of first antiplatelet, no. (%)
 Aspirin 101 (97%) 670 (99.6%) 12 (100%) .046
 Rectally administered for first dose? 28/101 (28%) 24/670 (4%) 1/12 (8%) <.01
 Non-aspirin 3 (3%) 3 (.5%) 0 (0%) .046

SLP denotes: speech and language pathology; RN: registered nurse; IQR: interquartile range; mRS: Modified Rankin Score; NIHSS: NIH Stroke Scale/Score; ASPECTS: Alberta Stroke Program Early CT Score; and ICA: internal carotid artery.

aNote: 105/789 (13%) patients had ≥1 point for dysarthria and ≥2 points for facial weakness, 221/789 (28%) had dysarthria without facial weakness, and 22/789 (3%) had facial weakness without dysarthria.

bASPECTS provided for patients with anterior circulation only infarctions.